GlassScriptPhysician profile
Nicole Palmer
NPI 1578054334
$3,245.92
in general payments reported to CMS, 2019-2025
19 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $174 · 2023: $1,030 · 2024: $943 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,072.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $587.67 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $497.63 | 2022-2025 | |
| Myriad Women'S Health, INC. | $394.23 | 2023 | Myrisk |
| Sumitomo Pharma America, INC. | $299.38 | 2024-2025 | Myfembree |
| Exeltis, USA INC. | $279.54 | 2022-2025 | Slynd |
| Agile Therapeutics, INC. | $190.03 | 2023-2024 | Twirla |
| Abbvie INC. | $182.25 | 2022-2023 | |
| Organon LLC | $181.89 | 2022-2025 | Nexplanon |
| Shield Therapeutics INC | $121.04 | 2024-2025 | |
| Astellas Pharma US INC | $106.34 | 2024-2025 | Veozah |
| Evofem Biosciences, INC. | $105.58 | 2022-2024 | Phexxi |
| Coopersurgical, INC. | $104.12 | 2022-2023 | Paragard T 380a |
| Scynexis, INC. | $52.50 | 2022 | |
| Daiichi Sankyo INC. | $27.80 | 2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $25.97 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.52 | 2025 | Gardasil 9 |
| Avion Pharmaceuticals | $23.77 | 2023 | Balcoltra |
| Pfizer INC. | $20.35 | 2024 | |
| Millicent US INC | $20.31 | 2025 | Femlyv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.